Anthony Reiman (Antony Reiman, Tony Reiman)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

British journal of haematology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Rayan Kaedbey, Donna Reece, Christopher P Venner, Arleigh McCurdy, Jiandong Su, Michael Chu, Martha Louzada, Victor H Jimenez-Zepeda, Hira S Mian, Kevin Song, Michael Sebag, Julie Stakiw, Darrell White, Anthony Reiman, Muhammad Aslam, Rami Kotb, Debra Bergstrom, Engin Gul, Richard LeBlanc
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database. EJHaem 5 (3) (2024)
Rayan Kaedbey, Donna Reece, Christopher P Venner, Arleigh McCurdy, Jiandong Su, Michael Chu, Martha Louzada, Victor H Jimenez-Zepeda, Hira S Mian, Kevin Song, Michael Sebag, Julie Stakiw, Darrell White, Anthony Reiman, Muhammad Aslam, Rami Kotb, Debra Bergstrom, Engin Gul, Richard LeBlanc
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database. EJHaem 5 (3) (2024)
Cecile J Proctor, Anthony Reiman, Lisa A Best
Working after cancer: psychological flexibility and the quality of working life. Journal of cancer survivorship : research and practice (2023)
Richard LeBlanc, Hira S Mian, Donna Reece, Jiandong Su, Esther Masih-Khan, Michael Chu, Victor H Jimenez-Zepeda, Michael Sebag, Kevin Song, Martha Louzada, Rami Kotb, Alissa Visram, Darrell White, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rayan Kaedbey, Engin Gul, Christopher P Venner
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. European journal of haematology (2023)
Richard LeBlanc, Hira Mian, Donna Reece, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Arleigh McCurdy, Kevin Song, Michael Sebag, Martha Louzada, Darrell White, Julie Stakiw, Rami Kotb, Anthony Reiman, Muhammad Aslam, Engin Gul, Christopher P Venner
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database. British journal of haematology 198 (1) (2022)
Arleigh McCurdy, Martha Louzada, Christopher P Venner, Alissa Visram, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Richard LeBlanc, Michael Sebag, Kevin Song, Darrell White, Hira S Mian, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Rami Kotb, Engin Gul, Donna Reece
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database. EJHaem 3 (4) (2022)
Stacy Grieve, Keyue Ding, Jonathan Moore, Mathew Finniss, Ayush Ray, Miranda Lees, Faisal Hossain, Alli Murugesan, Jane Agar, Cenk Acar, James Taylor, Frances A Shepherd, Anthony Reiman
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10. ESMO open 5 (2) (2021)
Samantha Fowler, Lauren McLaughlin, Sarah Bridges, Marc Robichaud, Barbara Ridgway, Donna Reece, Kevin Song, Lorelei Dalrymple, Robin Sully, Sharon Nason, Suzanne Rowland, Trish MacDonald, William Paine, Anthony Reiman
The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership. British journal of haematology (2021)
Victor H Jimenez-Zepeda, Christopher Venner, Arleigh McCurdy, Esther Masih-Khan, Eshetu G Atenafu, Michael Sebag, Julie Stakiw, Kevin Song, Richard LeBlanc, Anthony Reiman, Martha Louzada, Rami Kotb, Engin Gul, Donna Reece
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database. British journal of haematology 193 (3) (2021)
Alli Murugesan, Grégoire Lassalle-Claux, Lauren Hogan, Elise Vaillancourt, Ayyoub Selka, Katie Luiker, Min Ji Kim, Mohamed Touaibia, Anthony Reiman
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis. Journal of natural products 83 (12) (2020)